Full Professor of Neurosciences and Neurochemistry, Department of Biomedical Sciences, University of Antwerp
Director, Reference Center for Biological Markers of Dementia (BIODEM), Department of Biomedical Sciences, University of Antwerp
Chair, Department of Neurology, UZ Brussel
- MD, Free University of Brussels (V.U.B.), 1995
- Neurologist (Belgian Board Certification), University of Antwerp, 2001
- PhD in Medical Sciences, University of Antwerp, 2004
- Specialist in Neurological Revalidation (Belgian Board Certification), UAntwerp, 2009
Sebastiaan Engelborghs was born on September 21st, 1970 in Brussels, Belgium. He obtained his degree as medical doctor with summa cum laude in 1995 at the Free University of Brussels (V.U.B.). He then followed a Master after Master in Clinical Neurology and became a board certified neurologist in 2001 at UAntwerp where he also obtained a PhD in medical sciences (2004). In 2004, he established the Reference Centre for Biological Markers of Dementia (BIODEM) at UAntwerp and was appointed assistant professor. In 2008, Dr. Engelborghs was promoted to associate professor and became coordinator of the Memory Clinic, Department of Neurology, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken. He was board certified in Neurological Revalidation in 2009. In 2011, he was appointed research professor neurosciences – neurochemistry at the University of Antwerp and became full professor neurosciences – neurochemistry in 2014.
Both clinically and with regard to research, Sebastiaan Engelborghs is specialized in neurodegenerative brain disorders that cause cognitive impairment and dementia. Between 2008 and 2019, Sebastiaan Engelborghs coordinated the Memory Clinic of the Department of Neurology of ZNA Middelheim and Hoge Beuken. In 2019, he became chair and full professor of neurology at UZ Brussel and VUB. His research resulted in (co-)authorships on 309 PubMed-cited papers in international peer-reviewed journals and an h-index of 59 (FEB 2020). Research initially focused on the validation of existing CSF biomarkers for AD and the BIODEM lab was the first to validate these biomarkers in autopsy-confirmed patients. Several studies on standardization and harmonization of (the pre-analytical and analytical steps of) CSF biomarker analyses were published. His research has significantly contributed to the integration of AD CSF biomarkers into the research diagnostic criteria of AD, like the IWG criteria that he co-authored.
Sebastiaan Engelborghs is laureate of several prices and awards and is board member of several national and international professional organizations. He is secretary-general of the Belgian Neurological Society, vice-president of the Belgian Dementia Council (BeDeCo) and is an ExCo member of the European Alzheimer Disease Consortium.